Pharmaceutical Sales Manager

S.Talley

Stephanie E. Talley

South Florida • *****.*.******@*****.*** • 949-***-**** • www.linkedin.com/in/stephanie-talley SALES LEADER DRIVING SALES REVENUE, COMPETITIVE ADVANTAGE & PATIENT CENTRICITY Award winning, performance driven specialty sales leader driving results in Biopharmaceuticals. Accomplished Regional Business Manager skilled in quickly learning and understanding a marketplace. Adept at turning around underperforming territories through successful cold-calling, collaborative team-building and focused professional development. Recognized for effective teams, creating customer satisfaction and working cross functionally. Known for leadership, performance management, adaptability, business acumen, change management, and strategic thinking. Key expertise in: Comprehensive Account Management • Sales Training • Product Launch • Biologics • Hospital Sales • Rare Disease • Specialty Pharmacy • Reimbursement • Buy and Bill • Project Management PROFESSIONAL EXPERIENCE

AKCEA THERAPEUTICS, Cambridge, MA 2018-PRESENT

Rare Disease Specialist (RDS), Rare Disease, Cardiology, Hematology, Neurology, Nuclear Medicine, Pathology First of ten Rare Disease Specialists hired nationally to uncover the appropriate health care professionals treating hereditary transthyretin amyloidosis (hATTR) in large teaching hospitals as well as community-based HCP points of interest across South Florida, Puerto Rico and the US Virgin Islands. Charged with both learning current diagnostic protocols across specialties, as well as educating clinicians about emerging diagnostic methodology and increasing disease state awareness in preparation of Tegsedi ( inotersen SC) launch.

• Launched the world’s first subcutaneous injectable RNA targeting therapy for Hereditary Amyloidosis Transthyretin : Tegsedi ( inotersen)

• Developed KOLs at the following centers: Cleveland Clinic, Florida Cancer Center Specialists, University of Miami, University of Puerto Rico, Veterans Administration of the Caribe, and First Choice Neurology

• Uncover diagnostic protocols and provide extensive disease state and diagnostic education for clinicians

• Along with internal Patient Services Group, partner with advocacy groups such as the Amyloidosis Research Consortium (ARC) and Amyloidosis Support Groups.org to uncover opportunities to educate patients and clinicians as well as uncover potential treating HCPs across Florida

• Successfully identified 53 patients through disease state awareness campaign

• Actively participate in the following conferences: FLASCO, FSNEURO, ACCFL, ASNC, ASH, Sociedad Puertorriquena de Cardiologia and Academia Puertorriquena de Neurologia

• Initiated and currently lead monthly team journal club based on clinical articles related to disease state and diagnostic pathways of hATTR

• Assist with ongoing training of newly hired teammates and serve as resource for inquiries related to internal processes and streamlining the creation of applicable target lists through effective questioning

• Serve as RDS representative on Field Advisory Board (FAB) with marketing, market access and senior leadership to help formulate strategy, marketing direction and messaging

• Partner with Patient Services Team (Akcea Connect) on developing materials and strategies around providing HCP REMs education and reinforcement, broad patient support for medication access, laboratory monitoring, and peer to peer patient connection S.Talley

2

SHIRE HGT/RARE DISEASE COMMERCIAL OPERATIONS, Cambridge, MA 2014-2018 Regional Business Manager, Endocrinology, Allergy, Hematology & Oncology, Rare Disease, 2014-2018 Natpara Regional Business Manager, Greater Philadelphia Area, October 2016 - April 2018 Cinryze Regional Business Manager, Greater Philadelphia Area, February 2014 – October 2016

• Launched Natpara (parathyroid hormone recombinant SC ), a novel therapy for hypocalcemia in patients with hypoparathyroidism

• Ranked 14/78 territories nationally 2017

• Executed HCP and Patient programs expanding additional $1.5M Natpara territory revenue, 2017

• Appointed as Natpara Regional Sales Trainer 2017

• Promoted Cinryze (C1 esterase inhibitor IV) with hub and specialty pharmacy access program

• Ranked 7/32 nationally 2016

• Winner of Vice President’s Club Award, 5/32 nationally 2015

• Ranked 4/32 nationally 2014

• Appointed by the Sales Director to serve as HAE National Field Sales Trainer, 2015

• Exceeded sales quota, 2017, 2016, 2015, 2014

PURACAP PHARMACEUTICALS, LLC., South Plainfield, NJ 2013-2014 Regional Sales Manager, Dermatology, PA, NJ & NYC

Promoted EpiCeram (skin barrier emulsion for dermatitis) to Dermatologists, Plastic Surgeons, and Allergists

• Ranked #3 of 21 nationally, 2014

BAUSCH & LOMB, Madison, NJ 2009-2013

Ocular Specialty Representative, Ophthalmologists, Ocular Oncologists, Optometrists, Philadelphia, PA Recruited to launch Besivance (besifloxacin hydrochloride), Prolensa (bromfenac ophthalmic solution) along with a promoting a diverse portfolio of ocular medications

• President’s Club Award Winner, 2009

TAKEDA PHARMACEUTICAL, Deerfield, IL 2006-2009

Diabetes Specialty Sales Representative, Endocrinology, Internal Medicine, Cherry Hill, NJ Accomplished aggressive territory-wide sales results for Actos (pioglitazone),ActoplusMet

(metformin/pioglitazone), and Niaspan (niacin)

• Ranked 40/550 nationally, 2008

OSCIENT PHARMACEUTICALS, Waltham, MA 2004-2006

Infectious Disease Sales Specialist, Pathology, Infectious Disease HCPs, Internal Medicine Philadelphia, PA Recruited to launch Factive (Gemifloxacin) to physicians, mid-level professionals and hospitals

• President’s Club 2005

EDUCATION

SAINT JOSEPH’S UNIVERSITY, PHILADELPHIA, PA

Bachelor of Science, Marketing - Major: Pharmaceutical Marketing ACTIVITIES AND INTERESTS

Dementia Society of America, Local Chapter Volunteer • Healthcare Business Women’s Association • National Class E Scow Association (sailing)

Contact this candidate